113 related articles for article (PubMed ID: 7482725)
1. A synthetic dimeric HLA class I peptide inhibits T cell activity in vitro and prolongs allogeneic heart graft survival in a mouse model.
Woo J; Gao L; Cornejo MC; Buelow R
Transplantation; 1995 Nov; 60(10):1156-63. PubMed ID: 7482725
[TBL] [Abstract][Full Text] [Related]
2. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
Gao L; Woo J; Buelow R
J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer of immunomodulatory peptides correlates with heme oxygenase-1 induction and enhanced allograft survival.
DeBruyne LA; Magee JC; Buelow R; Bromberg JS
Transplantation; 2000 Jan; 69(1):120-8. PubMed ID: 10653390
[TBL] [Abstract][Full Text] [Related]
4. Prolongation of allogeneic heart graft survival in rats by administration of a peptide (a.a. 75-84) from the alpha 1 helix of the first domain of HLA-B7 01.
Cuturi MC; Josien R; Douillard P; Pannetier C; Cantarovich D; Smit H; Ménoret S; Pouletty P; Clayberger C; Soulillou JP
Transplantation; 1995 Mar; 59(5):661-9. PubMed ID: 7886788
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody to the HLA class I alpha 3 domain inhibits T cell activation and prolongs cardiac allograft survival in HLA-transgenic mice.
Woo J; Cornejo MC; Gao L; Taurog JD; Hammer RE; Buelow R
Transpl Immunol; 1997 Jun; 5(2):112-21. PubMed ID: 9269033
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
Transplantation; 1999 Nov; 68(9):1402-9. PubMed ID: 10573082
[TBL] [Abstract][Full Text] [Related]
7. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
[TBL] [Abstract][Full Text] [Related]
11. Decreased cytotoxic activity of natural killer cells in kidney allograft recipients treated with human HLA-derived peptide.
Giral M; Cuturi MC; Nguyen JM; Josien R; Dantal J; Floc'h R; Buelow R; Pouletty P; Soulillou JP
Transplantation; 1997 Apr; 63(7):1004-11. PubMed ID: 9112355
[TBL] [Abstract][Full Text] [Related]
12. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
[TBL] [Abstract][Full Text] [Related]
13. Computer-assisted rational design of immunosuppressive compounds.
Grassy G; Calas B; Yasri A; Lahana R; Woo J; Iyer S; Kaczorek M; Floc'h R; Buelow R
Nat Biotechnol; 1998 Aug; 16(8):748-52. PubMed ID: 9702773
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
15. Prolongation of skin allograft survival in mice following administration of ALLOTRAP.
Buelow R; Veyron P; Clayberger C; Pouletty P; Touraine JL
Transplantation; 1995 Feb; 59(4):455-60. PubMed ID: 7878745
[TBL] [Abstract][Full Text] [Related]
16. Immunostimulatory and immunomodulatory peptides derived from the alpha1 domain of HLA-B27 in experimental autoimmune diseases in Lewis rats.
Diedrichs-Möhring M; Wildner G
Immunobiology; 2005; 209(10):711-7. PubMed ID: 15969447
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression by D-isomers of HLA class I heavy chain (amino acid 75 to 84)-derived peptides is independent of binding to HSC70.
Woo J; Iyer S; Cornejo MC; Gao L; Cuturi C; Soulillou JP; Buelow R
Transplantation; 1997 Nov; 64(10):1460-7. PubMed ID: 9392312
[TBL] [Abstract][Full Text] [Related]
18. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance.
Chavin KD; Qin L; Woodward JE; Lin J; Bromberg JS
Transplantation; 1994 Mar; 57(5):736-40. PubMed ID: 7511258
[TBL] [Abstract][Full Text] [Related]
20. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
